Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

Year End Trading Update

16 Nov 2021 07:00

RNS Number : 4453S
IDOX PLC
16 November 2021
 

16 November 2021

Idox plc

('Idox' or the 'Group' or the 'Company')

Year End Trading Update

A year of strong financial and operational execution

 

Idox plc (AIM: IDOX), a leading supplier of specialist information management software and solutions to the public and asset intensive sectors, today issues a trading update for its financial year ended 31 October 2021 ('FY21').

 

Financial highlights

 

During the year the Group continued to sharpen its strategic focus and disposed of its Content division in two separate transactions. 'Continuing operations' exclude these disposed Content businesses.

 

The Group expects to report the following results for the year, in line with the Board's expectations (continuing operations except where stated):

 

· Revenue increased by 8% to £62.0m (2020: £57.3m).

· Recurring revenue increased by 2% to £36.4m (2020: £35.7m).

· Adjusted EBITDA* increased by 12% to £19.3m (2020: £17.2m).

· Total operations (including a contribution from the disposed Content businesses for 5 months in FY21) recorded revenues of £65.9m (2020: £68.0m) and adjusted EBITDA* of £19.6m (2020: £19.6m).

· A material reduction in net debt at 31 October 2021 to £8.1m (2020: £16.1m):

o A net debt to Adjusted EBITDA ratio of 0.4x (2020: 0.8x), with available liquidity of £38m.

o Includes impact of disposal proceeds of £12.6m from the sale of the Content businesses and initial consideration of £12.9m for acquisitions of Aligned Assets and exeGesIS.

o Completed extension of bank facilities by another 18 months to June 2024.

· Following payment of our reinstated dividend in April 2021, we intend to propose a final dividend for the financial year just ended on the release of our final results.

 

Operational highlights

 

FY21 has seen continued delivery of the Group's strategic goals following the Group's transformation over the previous two financial years.

 

Highlights include:

· Good progress with our M&A strategy to focus capital on core, high margin operations with good growth potential:

o Disposal of Content businesses, in line with our continued simplification and focus on software operations.

o Acquisition of Aligned Assets, thinkWhere and exeGesIS, which enhance our Public Sector offering and provide greater focus and depth of expertise in the GIS market.

o Further development of our M&A ambitions in both sourcing and managing pipeline opportunities.

· Continued improvements to our sales and marketing activity; now fully managed and reported in our new CRM platform (implemented in 2020).

· Enhanced focus on innovation and consolidation of our product portfolio, including continuing our journey to cloud.

· Further investment in our people and our commitment to environmental, social and governance initiatives.

 

David Meaden, Chief Executive of Idox commented:

 

"We have had another strong year, reshaping the Group to focus on our public sector and engineering software core, alongside delivering an excellent financial and non-financial performance.

 

We exited our Content businesses in March this year and acquired three excellent Public Sector software businesses, whilst improving our balance sheet strength.

 

We have made good progress in the year improving operational cadence within our four pillars of improving revenue, margin, communication and simplicity. We have emphasised investments in our people and leadership; and in systems and process to drive both efficiency and scalability in our operations as we continue to expand both organically and inorganically.

 

The outlook for the business remains positive and we are now firmly in our 'fly' stage of growth. We have entered the new financial year with good momentum and look forward to the contribution of our new acquisitions."

 

Notice of results

 

The Group expects to report its FY21 results in early February 2022. Management intends to host a results webinar on the day. Please contact MHP Communications to register your interest.

 

 

* Adjusted EBITDA is defined as earnings before amortisation, depreciation, restructuring, acquisition costs, impairment, financing costs and share option costs.

 

** Net debt is defined as the aggregation of cash, bank borrowings and long-term bond.

 

 

For further information please contact:

 

Idox plc

+44 (0) 870 333 7101

David Meaden, Chief Executive

Rob Grubb, Chief Financial Officer

Peel Hunt LLP (NOMAD and Broker)

+44 (0) 20 7418 8900

Edward Knight

Paul Gillam

MHP Communications

+ 44 (0) 203 128 8170

Reg Hoare

 idox@mhpc.com

James Bavister

 

About Idox plc

For more information see www.idoxplc.com @Idoxgroup 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDKPBNOBDDNDD
Date   Source Headline
24th Apr 20184:32 pmRNSHolding(s) in Company
24th Apr 201810:24 amRNSHolding(s) in Company
23rd Apr 20183:40 pmRNSHolding(s) in Company
19th Apr 20183:58 pmRNSResult of AGM and Board Change
19th Apr 20183:54 pmRNSAGM Statement and Trading Update
19th Apr 20187:00 amRNSAGM Statement and Trading Update
27th Mar 20185:17 pmRNSDirector/PDMR Shareholding
27th Mar 201811:02 amRNSPosting of Annual Report and Notice of AGM
22nd Mar 20185:27 pmRNSHolding(s) in Company
19th Mar 201811:22 amRNSHolding(s) in Company
15th Mar 20185:17 pmRNSVesting of LTIP
8th Mar 20184:43 pmRNSHolding(s) in Company
1st Mar 201812:25 pmRNSDirectorate Change
1st Mar 201811:30 amRNSHolding(s) in Company
1st Mar 20187:00 amRNSFinal Results
20th Feb 201812:24 pmRNSHolding(s) in Company
2nd Feb 20184:12 pmRNSHolding(s) in Company
2nd Feb 20188:58 amRNSHolding(s) in Company
31st Jan 20184:52 pmRNSHolding(s) in Company
25th Jan 201812:34 pmRNSDirector/PDMR Shareholding
5th Jan 20184:40 pmRNSSecond Price Monitoring Extn
5th Jan 20184:35 pmRNSPrice Monitoring Extension
3rd Jan 201810:51 amRNSHolding(s) in Company
27th Dec 20171:48 pmRNSHolding(s) in Company
13th Dec 20177:00 amRNSYear End Update and Board Change
14th Nov 20173:45 pmRNSYear End Trading Update
2nd Nov 20171:31 pmRNSDirector Update
22nd Sep 20172:33 pmRNSExercise of Options and Total Voting Rights
20th Sep 20179:32 amRNSHolding(s) in Company
4th Sep 201710:38 amRNSDirectors' Dealing, Exercise of Options & TVR
1st Sep 20176:16 pmRNSHolding(s) in Company
23rd Aug 20176:06 pmRNSHolding(s) in Company
17th Aug 20177:00 amRNSAcquisition
4th Aug 20174:20 pmRNSDirector and PCA Dealing
14th Jul 20173:52 pmRNSDirector/PDMR Shareholding
6th Jul 20174:35 pmRNSPrice Monitoring Extension
29th Jun 20175:23 pmRNSDirector/PDMR Shareholding and Total Voting Rights
6th Jun 20177:00 amRNSHalf-year Report
18th May 20177:00 amRNSHalf Year Trading Update and Notice of Results
17th May 20174:31 pmRNSHolding(s) in Company
18th Apr 20173:45 pmRNSDirector/PDMR Shareholding and Total Voting Rights
7th Apr 20172:27 pmRNSDirector/PDMR Shareholding
22nd Mar 20179:22 amRNSDirector and PCA Dealing
24th Feb 201712:53 pmRNSResult of AGM
24th Feb 20177:00 amRNSAGM Trading Update
15th Feb 20172:55 pmRNSHolding(s) in Company
14th Feb 20171:24 pmRNSExercise of Options and Total Voting Rights
10th Feb 20173:39 pmRNSDirector/PDMR Shareholding
6th Feb 20176:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20179:48 amRNSDirectors' Dealing, Exercise of Options and TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.